37th Annual Advances in Heart Disease


 

Results of the COMPASS and VOYAGER PAD Trials: Is Rivaroxaban in Combination with Aspirin More Effective than Aspirin Alone for Secondary Cardiovascular Prevention in Patients with PAD?

839 views
February 11, 2021
1 Comment
Login to view comments. Click here to Login
Day 1